Funds · RARE

Who owns RARE?

Institutional ownership of Ultragenyx Pharmaceutical Inc. from Form 13F, Q2 2026

310 institutional managers reported holding Ultragenyx Pharmaceutical Inc. (RARE) in Form 13F filings for Q2 2026, with 106,897,175 shares worth $3.6B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 8,799,085 shares (+9.0%). 56 opened new positions and 42 sold out.

Funds holding
310
Value held
$3.6B
New / sold out
56 / 42
Net shares, same filers
+9.0%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of RARE

FundValueShare of 13F holdingsSharesMove
BlackRock, Inc.$356M10.0%10,654,276Added
RTW Investments, LP$260M7.3%7,796,895Added
Vanguard Portfolio Management LLC$227M6.4%6,790,135Added
AQR Capital Management LLC$214M6.1%6,560,809Added
State Street Corp$206M5.8%6,158,766Added
Vanguard Capital Management LLC$143M4.0%4,296,491Added
Two Sigma Investments, LP$121M3.4%3,621,200Added
Sands Capital Management, LLC$105M3.0%3,158,368Trimmed
Jacobs Levy Equity Management, Inc$98.2M2.8%2,939,719Added
Frontier Capital Management Co LLC$95.1M2.7%2,847,936Added
Geode Capital Management, LLC$86.1M2.4%2,578,828Added
Bellevue Group AG$66.2M1.9%1,982,775Trimmed
D. E. Shaw & Co., Inc.$57.8M1.6%1,730,193Added
Sofinnova Investments, Inc.$57.3M1.6%1,717,505Trimmed
Adage Capital Partners GP, L.l.c.$52.8M1.5%1,580,000Added
GW&K Investment Management, LLC$49.5M1.4%1,481,178Trimmed
MPM Bioimpact LLC$47.4M1.3%1,418,215New
Price T Rowe Associates Inc$45.3M1.3%1,356,501Added
Morgan Stanley$44.2M1.2%1,324,805Trimmed
Wellington Management Group LLP$41.8M1.2%1,250,464Trimmed
Voloridge Investment Management, LLC$41.5M1.2%1,241,556Trimmed
Bank of America Corp$38.3M1.1%1,148,454Added
Candriam S.C.A.$33.4M0.9%1,001,841Trimmed
Rock Springs Capital Management LP$32.3M0.9%967,855Trimmed
Jefferies Financial Group Inc.$31.0M0.9%929,626Added

Share of 13F holdings is each fund's shares as a share of the 106,897,175 RARE shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $916M and sold $565M; 115 added and 97 trimmed.

Schedule 13D and 13G filings on RARE

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about RARE ownership

Who owns RARE stock?
310 institutional investment managers reported RARE positions in their Form 13F filings for Q2 2026, holding 106,897,175 shares worth $3.6B in total. BlackRock, Inc. reported the largest position.
Are funds buying or selling RARE?
In Q2 2026, 56 managers opened new RARE positions, 115 added, 97 trimmed and 42 sold out. Managers that filed in both quarters added a net 8,799,085 shares.
How current is this RARE institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to RARE by CUSIP. Options are left out. RARE news and filings · RARE insider trades · Top funds